{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T02:08:21Z","timestamp":1777514901162,"version":"3.51.4"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2020,7,6]],"date-time":"2020-07-06T00:00:00Z","timestamp":1593993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,7,6]],"date-time":"2020-07-06T00:00:00Z","timestamp":1593993600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Gastrointest Canc"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1007\/s12029-020-00452-6","type":"journal-article","created":{"date-parts":[[2020,7,6]],"date-time":"2020-07-06T00:02:22Z","timestamp":1593993742000},"page":"1094-1101","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Family History of Cancer as Potential Prognostic Factor in Stage III Colorectal Cancer: a Retrospective Monoinstitutional Study"],"prefix":"10.1007","volume":"51","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4629-7762","authenticated-orcid":false,"given":"Alessandro","family":"Parisi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessio","family":"Cortellini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olga","family":"Venditti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valentina","family":"Santo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tina","family":"Sidoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katia","family":"Cannita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Corrado","family":"Ficorella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giampiero","family":"Porzio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,7,6]]},"reference":[{"issue":"Suppl 1","key":"452_CR1","first-page":"S61","volume":"8","author":"J Little","year":"1999","unstructured":"Little J, Faivre J. Family history, metabolic gene polymorphism, diet and risk of colorectal cancer. Eur J Cancer Prev. 1999;8(Suppl 1):S61\u201372.","journal-title":"Eur J Cancer Prev"},{"issue":"2","key":"452_CR2","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1038\/ajg.2014.435","volume":"110","author":"S Syngal","year":"2015","unstructured":"Syngal S, Brand RE, Church JM, Giardiello FM, Hampel HL, Burt RW, et al. ACG clinical guideline: genetic testing and management of hereditary gastrointestinal cancer syndromes. Am J Gastroenterol. 2015;110(2):223\u201362; quiz 263. https:\/\/doi.org\/10.1038\/ajg.2014.435.","journal-title":"Am J Gastroenterol"},{"key":"452_CR3","doi-asserted-by":"publisher","unstructured":"Schiemann U, Muller-Koch Y, Gross M, et al. Extended microsatellite analysis in microsatellite stable, MSH2 and MLH1 mutation-negative HNPCC patients: genetic reclassification and correlation with clinical features. Digestion. 2004;69(3):166\u201376. https:\/\/doi.org\/10.1159\/000078223.","DOI":"10.1159\/000078223"},{"issue":"8","key":"452_CR4","doi-asserted-by":"publisher","first-page":"643","DOI":"10.2217\/imt-2017-0167","volume":"10","author":"A Cortellini","year":"2018","unstructured":"Cortellini A, Bersanelli M, Buti S, Gambale E, Atzori F, Zoratto F, et al. Family history of cancer as surrogate predictor for immunotherapy with anti-PD1\/PD-L1 agents: preliminary report of the FAMI-L1 study. Immunotherapy. 2018;10(8):643\u201355. https:\/\/doi.org\/10.2217\/imt-2017-0167.","journal-title":"Immunotherapy."},{"issue":"1","key":"452_CR5","doi-asserted-by":"publisher","first-page":"1710389","DOI":"10.1080\/2162402X.2019.1710389","volume":"9","author":"A Cortellini","year":"2020","unstructured":"Cortellini A, Buti S, Bersanelli M, Giusti R, Perrone F, di Marino P, et al. Evaluating the role of FAMIly history of cancer and diagnosis of multiple neoplasms in cancer patients receiving PD-1\/PD-L1 checkpoint inhibitors: the multicenter FAMI-L1 study. Oncoimmunology. 2020;9(1):1710389. https:\/\/doi.org\/10.1080\/2162402X.2019.1710389.","journal-title":"Oncoimmunology."},{"key":"452_CR6","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1158\/1055-9965.1253.13.7","volume":"13","author":"K Hemminki","year":"2004","unstructured":"Hemminki K, Chen B. Familial risk for colorectal cancers are mainly due to heritable causes. Cancer Epidemiol Biomark Prev. 2004;13:1253\u20136.","journal-title":"Cancer Epidemiol Biomark Prev"},{"issue":"7","key":"452_CR7","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.1038\/bjc.2013.91","volume":"108","author":"EJ Morris","year":"2013","unstructured":"Morris EJ, Penegar S, Whitehouse LE, Quirke P, Finan P, Bishop DT, et al. A retrospective observational study of the relationship between family history and survival from colorectal cancer. Br J Cancer. 2013;108(7):1502\u20137. https:\/\/doi.org\/10.1038\/bjc.2013.91.","journal-title":"Br J Cancer"},{"key":"452_CR8","doi-asserted-by":"publisher","first-page":"2192","DOI":"10.1002\/cam4.1470","volume":"7","author":"DQ Chong","year":"2018","unstructured":"Chong DQ, Banbury BL, Phipps AI, Hua X, Kocarnik J, Peters U, et al. Association of family history and survival in patients with colorectal cancer: a pooled analysis of eight epidemiologic studies. Cancer Med. 2018;7:2192\u20139.","journal-title":"Cancer Med"},{"issue":"1","key":"452_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.21037\/jgo.2016.12.13","volume":"8","author":"CL Jansson-Knodell","year":"2017","unstructured":"Jansson-Knodell CL, Foster NR, Sargent DJ, Limburg PJ, Thibodeau SN, Smyrk TC, et al. Family history of colorectal cancer and its impact on survival in patients with resected stage III colon cancer: results from NCCTG Trial N0147 (Alliance). J Gastrointest Oncol. 2017;8(1):1\u201311. https:\/\/doi.org\/10.21037\/jgo.2016.12.13.","journal-title":"J Gastrointest Oncol"},{"key":"452_CR10","doi-asserted-by":"publisher","first-page":"2515","DOI":"10.1001\/jama.299.21.2515","volume":"299","author":"JA Chan","year":"2008","unstructured":"Chan JA, Meyerhardt JA, Niedzwiecki D, Hollis D, Saltz LB, Mayer RJ, et al. Association of family history with cancer recurrence and survival among patients with stage III colon cancer. JAMA. 2008;299:2515\u201323.","journal-title":"JAMA"},{"issue":"4","key":"452_CR11","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1097\/CEJ.0000000000000482","volume":"28","author":"T Shan","year":"2019","unstructured":"Shan T, Chen S, Chen X, Lin W, Li W, Ma J, et al. Association of family history of tumors with clinicopathological characteristics and prognosis of colorectal cancer. Eur J Cancer Prev. 2019;28(4):258\u201367. https:\/\/doi.org\/10.1097\/CEJ.0000000000000482.","journal-title":"Eur J Cancer Prev"},{"key":"452_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15430\/JCP.2019.24.1.1","volume":"24","author":"Y Park","year":"2019","unstructured":"Park Y, Park SJ, Cheon JH, Kim WH, Kim TI. Association of family history with cancer recurrence, survival, and the incidence of colorectal adenoma in patients with colorectal cancer. J Cancer Prev. 2019;24:1\u201310.","journal-title":"J Cancer Prev"},{"key":"452_CR13","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1245\/s10434-019-07179-0","volume":"26","author":"SY Lee","year":"2019","unstructured":"Lee SY, Kim DW, Kang SI, Ihn MH, Oh HK, Kang SB, et al. Impact of family history on prognosis of patients with sporadic colorectal cancer. Ann Surg Oncol. 2019;26:1118\u201326.","journal-title":"Ann Surg Oncol"}],"container-title":["Journal of Gastrointestinal Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12029-020-00452-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12029-020-00452-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12029-020-00452-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T05:07:15Z","timestamp":1667279235000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12029-020-00452-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,6]]},"references-count":13,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["452"],"URL":"https:\/\/doi.org\/10.1007\/s12029-020-00452-6","relation":{},"ISSN":["1941-6628","1941-6636"],"issn-type":[{"value":"1941-6628","type":"print"},{"value":"1941-6636","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,6]]},"assertion":[{"value":"6 July 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Dr. Alessio Cortellini received grants as speaker from MSD, Astra-Zeneca, and Boehringer Ingelheim and grant consultancies from BMS, Roche, Novartis, Istituto Gentili and Ipsen.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"The procedures followed were in accordance with the precepts of Good Clinical Practice and the Declaration of Helsinki. The study was conducted following the rules of the local bioethical committee competent on human experimentation (Comitato etico per le province di L\u2019Aquila e Teramo).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Statement"}}]}}